Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical ruxolitinib in non-segmental vitiligo
NCT04052425Phase 3Completed
- Sponsor
- Incyte
- Start
- Sep 2019
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of ruxolitinib cream in nonsegmental vitiligo (NSV), sponsored by Incyte. Started Sep 2019; status: completed.
02
Drugs
ruxolitinib cream
03
Conditions
nonsegmental vitiligo (NSV)
Beyond the preview
Go deeper on NCT04052425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04052425.